Cardiac Paraganglioma—A Rare Subset of a Rare Tumor

Tudor, A; Tschui, Joëlle; Schmidli, Jürg; Schmid, Ralph A.; Dorn, Patrick

doi:10.4236/wjcd.2017.71001

Cited by 2 publications

(2 citation statements)

References 21 publications

(13 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These masses include teratomas, hamartomas, fibromas, hemangiomas, paragangliomas, and mesotheliomas of the atrioventricular node [50,51]. Management is often similar to other cardiac masses and based on presenting symptoms, concern for embolic risk or obstructive physiology, and clinical risk of surgical intervention [52]. Because of the rarity of these types of tumors, little is known about pre-operative incidence.…”

Section: Note: the Surgical Specimen Is From The Same Patient As The mentioning

confidence: 99%

Non-Malignant Cardiac Tumors

Eapen¹,

Malone²,

Hanna³

et al. 2020

Embolic Diseases - Evolving Diagnostic and Management Approaches

View full text Add to dashboard Cite

Cardiac tumors represent an unusual clinical problem in that they are often discovered as an incidental finding during a routine echocardiogram or in the course of a work-up for a source of embolism. Malignant tumors of the heart are either defined as primary or metastatic from an extra-cardiac primary sourceregardless, the prognosis is poor. However, there are several cardiac tumors that are characterized as being non-malignant with regard to their tumor biology, but their tendencies to cause embolic or obstructive complications can be just as catastrophic despite a lack of invasiveness or potential to metastasize. The purpose of this chapter is to review the common types of non-malignant cardiac tumors with regard to their incidence, presentation, potential for complications, and management-with emphasis on surgical indications and techniques. 2 delineated as malignant and non-malignant with malignant tumors being either primary (i.e., cardiac sarcomas) or metastatic (i.e., breast carcinoma). They are distinguished from non-malignant tumors, such as myxomas and fibroelastomas, in that the latter, despite the pathologic implications of growth (i.e., valvular obstruction) and systemic embolism, lack true metastatic potential. Nevertheless, non-malignant cardiac tumors can be clinically devastating (i.e., malignant) by their tendency to cause potentially devastating, and occasionally fatal, embolic complications [5]. MethodsThe focus of this review is on non-malignant tumors. The review methods consisted of Google Scholar (https://scholar.google.com) and PubMed (https:// www.ncbi.nlm.nih.gov/pmc/) searches with emphasis on the following key words: cardiac tumors, benign cardiac masses, myxomas, fibroelastomas, and fibromas. Additional associated search terms included: surgery, diagnosis, imaging, and management. Selected references, including manuscript abstracts and full texts, were reviewed for relevance in the context of this review.

show abstract

Section: Note: the Surgical Specimen Is From The Same Patient As The mentioning

confidence: 99%

Non-Malignant Cardiac Tumors

Eapen¹,

Malone²,

Hanna³

et al. 2020

Embolic Diseases - Evolving Diagnostic and Management Approaches

View full text Add to dashboard Cite

show abstract

“…These tumours usually are isohomogenous on MRI and have features of an extremely vascular tumour. This can be made out on dynamic MRI 47. When they have invasive features, they have to be distinguished from lymphomas of the heart.…”

Section: Outcome and Follow-upmentioning

confidence: 99%

How does knowledge of the blood supply to an intracardiac tumour help?

Gupta¹,

Sagar²,

Ramachandran³

et al. 2019

BMJ Case Rep

View full text Add to dashboard Cite

Myxoma is a common benign tumour found in the heart. On reviewing literature, we found some left atrial myxomas receive blood supply from the right coronary artery. Performing a coronary angiogram in a cardiac tumour has the following uses: (1) it shows the vascularity that can be ligated by the surgeon at operation; (2) if there is a blood supply visible, it may not be an intracardiac thrombus; (3) the coronary angiogram may detect a myxoma even before an echocardiogram does so; (4) some myxomas may bleed into the right atrium or left atrium and this may be seen on coronary angiography. We show here the neovascularity of a left atrial myxoma and its blood supply from the right coronary artery. We recommend that all routine coronary angiograms be reviewed carefully for any signs of tumour vascularity or tumour blush as this would prevent missing early myxomas. Echocardiography is the gold standard for detection of myxomas but literature has a number of intracardiac tumours that were detected only by the tumour blush. Some left atrial tumours have been treated by occluding their blood supply.The absence of a blood supply on coronary angiography could rule out a benign cardiac tumour that usually has a blood supply.

show abstract

Cardiac Paraganglioma—A Rare Subset of a Rare Tumor

Cited by 2 publications

References 21 publications

Non-Malignant Cardiac Tumors

Non-Malignant Cardiac Tumors

How does knowledge of the blood supply to an intracardiac tumour help?

Contact Info

Product

Resources

About